We are live on ! Find out more
LAB icon

Standard BioTools
LAB

125 hedge funds and large institutions have $296M invested in Standard BioTools in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

503% more call options, than puts

Call options by funds: $1.56M | Put options by funds: $258K

12% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 41

7% less funds holding

Funds holding: 135 → 125 (-10)

9.63% less ownership

Funds ownership: 101.67% → 92.04% (-9.6%)

32% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 31

66% less capital invested

Capital invested by funds: $864M → $296M (-$569M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
125
Holders Change
-10
Holders Change %
-7.41%
% of All Funds
2.74%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
46
Reduced
41
Closed
31
Calls
$1.56M
Puts
$258K
Net Calls
+$1.3M
Net Calls Change
+$1.49M

Top Buyers

1
ICM
Indaba Capital Management
California
+$21.4M
2
PHS
PFM Health Sciences
California
+$13.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.17M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.24M
5
ECM
Endurant Capital Management
California
+$3.12M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$22.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$22.4M
3
Morgan Stanley
Morgan Stanley
New York
-$11.7M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$11.3M
5
Invesco
Invesco
Georgia
-$7.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$2.27M -$3.77M -478,225 -49%
Artisan Partners
27
Artisan Partners
Wisconsin
$2.05M +$195K +24,791 +6%
Goldman Sachs
28
Goldman Sachs
New York
$2M +$996K +126,425 +42%
Squarepoint
29
Squarepoint
New York
$1.92M +$1.86M +235,840 +132%
ECM
30
Endurant Capital Management
California
$1.83M +$3.12M +395,701 New
SSA
31
Schonfeld Strategic Advisors
New York
$1.55M -$2.06M -261,500 -44%
CAM
32
ClariVest Asset Management
California
$1.36M -$2.49M -315,653 -52%
CCM
33
Cadence Capital Management
Massachusetts
$1.24M +$23.1K +2,928 +1%
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.22M -$520K -66,008 -20%
Wells Fargo
35
Wells Fargo
California
$1.12M -$762K -96,709 -29%
PCM
36
Perkins Capital Management
Minnesota
$1.07M -$516K -65,517 -22%
Assenagon Asset Management
37
Assenagon Asset Management
Luxembourg
$966K +$814K +103,330 +98%
State of New Jersey Common Pension Fund D
38
State of New Jersey Common Pension Fund D
New Jersey
$965K +$1.64M +208,400 New
AC
39
Alexandria Capital
Virginia
$874K – – –
EGM
40
Engineers Gate Manager
New York
$811K +$323K +40,962 +30%
OAM
41
Oxford Asset Management
United Kingdom
$795K -$1.09M -138,806 -45%
Allianz Asset Management
42
Allianz Asset Management
Germany
$794K -$6.77M -859,124 -83%
Charles Schwab
43
Charles Schwab
California
$773K +$19.3K +2,454 +1%
QI
44
QS Investors
New York
$752K – – –
IP
45
Intellectus Partners
California
$732K – – –
LCS
46
Levin Capital Strategies
New York
$710K -$165K -21,000 -12%
SEI Investments
47
SEI Investments
Pennsylvania
$708K -$224K -28,451 -16%
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$651K +$1.11M +140,628 New
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$598K +$764K +97,000 +301%
Swiss National Bank
50
Swiss National Bank
Switzerland
$594K – – –
1
2
3 4 5

LAB Hedge Fund Activity: Q3 2019 in Review

125 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2019, worth a combined $296M — down 66% from $864M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of LAB and 21 opened new positions — a net loss of 10 holders — while 41 trimmed existing stakes and 46 added.

The largest buyer was Indaba Capital Management, opening a new position worth an estimated $21.4M. The largest seller was Easterly Investment Partners, cutting an estimated $22.7M.

  • 125 institutional investors held Standard BioTools (LAB) as of Q3 2019, down from 135 in Q2 2019.
  • Funds reported $296M of Standard BioTools stock for Q3 2019, down 66% quarter-over-quarter.
  • 21 funds opened new Standard BioTools positions in Q3 2019 and 31 closed out, a net change of -10 holders.
  • The largest Standard BioTools buyer in Q3 2019 was Indaba Capital Management, an estimated $21.4M added.
  • The largest Standard BioTools seller in Q3 2019 was Easterly Investment Partners, an estimated $22.7M sold.

Based on aggregated 13F filings for Q3 2019.